Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -32.14% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -43.94%. Over the past 30 days, the price of NUVB has leaped by -20.48%. And in the last five days, it has fallen by -8.84%.
Nuvation Bio Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $4.16 on 03/28/24 and the lowest value was $1.67 on 03/25/24.
52-week price history of NUVB Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Nuvation Bio Inc’s current trading price is -56.61% away from its 52-week high, while its distance from the 52-week low is 8.08%. The stock’s price range during this period has varied between$1.67 and $4.16. The Nuvation Bio Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.17 million for the day, a figure considerably lower than their average daily volume of 2.38 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Nuvation Bio Inc (NUVB) has experienced a quarterly decline of -37.76% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 609.31M and boasts a workforce of 51 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.5187, with a change in price of -0.4050. Similarly, Nuvation Bio Inc recorded 2,274,405 in trading volume during the last 100 days, posting a change of -18.16%.
NUVB’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for NUVB stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.00.
NUVB Stock Stochastic Average
As of today, Nuvation Bio Inc’s raw stochastic average for the last 50 days stands at 6.86%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 15.69%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 11.23% and 9.23%, respectively.
